FUNDAMENTALS · Fundamentals · HK Industrials

Meilleure Health International Industry Group (2327) Fundamentals 2026 — P/E 26.9x, Revenue Analysis | SniperIQ

Meilleure Health International Industry Group (2327) is a HK-listed Industrials company in Conglomerates with a market capitalization of HK

.0B, trading at HK$0.25 on the HKSE. This SniperIQ fundamentals page covers Meilleure Health International Industry Group's valuation (P/E 26.9x, P/B 0.8x), profitability (net margin 104.0%), revenue (HK
7M in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.

Market CapHK
.0B
P/E (TTM)26.9x
Net Margin104.0%
Revenue (FY25)HK
7M

Full research coverage

  • 8-Quarter Revenue & Margin Trend
  • Debt Maturity & Coverage
  • Peer Valuation Comparison
  • Free Cash Flow & Owner Earnings
  • AI Signal + Institutional Flow
  • DCF Valuation Model

Frequently Asked Questions

What is Meilleure Health International Industry Group's market cap?

Meilleure Health International Industry Group (2327) has a market capitalization of approximately HK

.0B, trading at HK$0.25 on the HKSE. Market cap moves with the live share price.

What is Meilleure Health International Industry Group's P/E ratio?

Meilleure Health International Industry Group's trailing twelve-month P/E ratio is 26.9x, with a price-to-book (P/B) of 0.8x. Valuation multiples are best compared with Industrials sector peers rather than read in isolation.

How profitable is Meilleure Health International Industry Group?

Meilleure Health International Industry Group runs a net profit margin of 104.0%, a gross margin of 62.0%, and an operating margin of -26.6%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does Meilleure Health International Industry Group generate?

Meilleure Health International Industry Group reported revenue of HK

7M for fiscal year 2025, with net income of HK
8M and earnings per share (EPS) of 0.0093. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.

Does Meilleure Health International Industry Group pay a dividend?

Meilleure Health International Industry Group offers a trailing dividend yield of about 2.2%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.

Is Meilleure Health International Industry Group financially healthy?

Meilleure Health International Industry Group carries a debt-to-equity ratio of 0.31x and a current ratio of 2.81x, with a market beta of 0.03. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is Meilleure Health International Industry Group a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Meilleure Health International Industry Group (2327) the key facts are: market cap HK

.0B, P/E 26.9x, revenue HK
7M, 52-week range 0.213-0.31. Weigh valuation, profitability, growth, and balance-sheet strength against Industrials peers and form your own view.

Track Meilleure Health International Industry Group's full fundamentals live

Get Meilleure Health International Industry Group's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.